Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 83,296Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1ChemWerth Inc

02 1BrightGene Bio-Medical Technology Co.,Ltd

03 1Curia

04 1Guangzhou Tosun Pharmaceutical

05 1Hameln rds

06 1Jiangsu Lianhuan Pharmaceutical

07 1KIVIPharm

08 1Lunan Pharmaceutical

09 1Sailong Pharmaceutical

10 1Sms Lifesciences

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Argatroban

About the Company : Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs ...

Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs to regulated markets worldwide and has exclusive partnerships for new product development, compliance support and secure supply chain logistics. ChemWerth has access to over 500 APIs and more than 30 manufacturing facilities in the US, Europe, India and China. ChemWerth acts as a regulatory agent for over 25 FDA-approved facilities and sells more than 100 products. It has established its presence in 38 countries. In 2020, ChemWerth filed its 500th DMF with the FDA.
Chemwerth Compnay Banner

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Argatroban

About the Company : BrightGene Bio-Medical Technology Co., Ltd. is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as well as special gener...

BrightGene Bio-Medical Technology Co., Ltd. is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as well as special generic APIs and FDFs with primary strategic focus on the regulated market. We have an exciting and very promising innovative pipeline including immuno-oncological therapeutic agents, orally available GLP-1RA peptides for type 2 diabetes, antibody drug conjugates for solid tumor, novel non-antibody dependent tumor targeting conjugates for brain cancer and solid tumor brain-metastasis.
blank

03

Curia

U.S.A
2024 ACI Convention
Not Confirmed
arrow

Curia

U.S.A
arrow
2024 ACI Convention
Not Confirmed

Argatroban

About the Company : Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners tur...

Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners turn their ideas into real-world impact. We partner closely with pharmaceutical and biotechnology companies to boost business performance and improve patients’ lives. From early discovery and development through manufacturing and commercialization, our suite of custom solutions allows us to tailor every engagement to your precise needs, whether that’s an independent project or an opportunity that cuts across the drug continuum.
blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Argatroban

About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...

Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Excipients, Herbal extracts, Formulation of Chinese & Western Medicine. With abundant economic strength, the group has successfully developed to a pharmaceutical group enterprise wich intergrets operation of medicine & related products, processing & manufacturing, and importation & exportation together.
blank

05

Hameln rds

Slovakia
2024 ACI Convention
Not Confirmed
arrow

Hameln rds

Slovakia
arrow
2024 ACI Convention
Not Confirmed

Argatroban

About the Company : Hameln rds s.r.o. located in Slovakia, Europe, part of the European Union, is a well-known pharmaceutical company producing APIs and services for the healthcare industry, with focu...

Hameln rds s.r.o. located in Slovakia, Europe, part of the European Union, is a well-known pharmaceutical company producing APIs and services for the healthcare industry, with focus on multiple steps during development and production of pharmaceutical products, covering analytical and galenical development of pharmaceuticals. Hameln provides a wide range of services like QC services (including stabilities and batch release) and development and manufacturing of APIs. Hameln rds is a centralized API production facility, supply, and trading chain, as well as research and development.
blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Argatroban

About the Company : Jiangsu Lianhuan Pharmaceutical Co., Ltd. was founded in 2000. It is a state-controlled competitive listed company. Its predecessor was Yangzhou Pharmaceutical Factory, which was e...

Jiangsu Lianhuan Pharmaceutical Co., Ltd. was founded in 2000. It is a state-controlled competitive listed company. Its predecessor was Yangzhou Pharmaceutical Factory, which was established in 1958. It achieved A-share listing in March 2003 with the stock code "600513". After years of reform and development, the company has grown into a national high-tech enterprise integrating R&D, production and sales. It enjoys a high reputation and reputation in the domestic and foreign pharmaceutical manufacturing fields. The company’s main products include urinary system drugs, antihistamines, cardiovascular drugs, steroid hormones, antibiotics etc
blank

07

KIVIPharm

China
2024 ACI Convention
Not Confirmed
arrow

KIVIPharm

China
arrow
2024 ACI Convention
Not Confirmed

Argatroban

About the Company : Kivipharm was established in 1973. After 40 years development, this company become one of the leading manufacturer of aseptic pharmaceutical products in china. Our products was exp...

Kivipharm was established in 1973. After 40 years development, this company become one of the leading manufacturer of aseptic pharmaceutical products in china. Our products was exported to more than 30 countries from Africa、Middle East、Russia and former CIS countries、South America and South East Asia. Our newly expanded facilities can support our increasing both by markets and by products.
blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Argatroban

About the Company : Lunan Pharmaceutical Group is an integrated pharmaceutical group setting production, scientific research and sale of traditional Chinese medicines, chemicals, biological products i...

Lunan Pharmaceutical Group is an integrated pharmaceutical group setting production, scientific research and sale of traditional Chinese medicines, chemicals, biological products in one, a national innovative enterprise, China Torch Program key high-tech enterprise. The group is composed of seven subsidiary enterprises including Lunan Hope Pharmaceutical Co., Ltd., Lunan Better Pharmaceutical Co., Ltd., Shandong New Time Pharmaceutical Co., Ltd., Lunan New Time Bio-Tech Co., Ltd., etc. It has been awarded the Top 500 Chinese Large Enterprise Group Competitiveness and Top 100 Taxpayers in Shandong Province for consecutive years.
blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Argatroban

About the Company : Sailong Pharmaceutical Group Co., Ltd. ("Salon Pharmaceutical" for short) was established in 2002. It is a high-tech enterprise integrating drug research and development, productio...

Sailong Pharmaceutical Group Co., Ltd. ("Salon Pharmaceutical" for short) was established in 2002. It is a high-tech enterprise integrating drug research and development, production and sales. Its current products are mainly concentrated in the nervous system, cardiovascular and cerebrovascular systems. and digestive system. After twenty years of hard work, the company has established the corporate purpose of "leading technology to achieve health care" since its establishment, focusing on drug research and development in line with international standards, and has successfully developed monosialotetrahexosylganglioside.
blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Argatroban

About the Company : SMS Lifesciences is a global player in APIs/Intermediates manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off a...

SMS Lifesciences is a global player in APIs/Intermediates manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments. SMS Group was given the export house status in the year 1997-98. SMS Lifesciences is currently a public listed company having ever appreciating International and Domestic customer base.
blank

Argatroban Manufacturers | Traders | Suppliers

Argatroban Manufacturers, Traders, Suppliers 1